USPTO serial 99329680
DMI
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- FOSBERG, MADELEINE E
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with DMI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Scottsdale, AZ, US
Scottsdale, AZ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eric T. Fingerhut
Eric T. Fingerhut Dykema Gossett, PLLC1301 K Street, NWSuite 1100 WestWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software as a Medical Device (SaMD), downloadable, for analyzing diagnostic biomarkers in patient blood, urine, and saliva to measure, screen, and monitor patient vital signs, oral and systemic health in the nature of oral diseases, medical conditions, and dental diseases, and social habits related to health for screening, assessment, and monitoring purposes; Software as a Medical Device (SaMD), downloadable, for analyzing patient blood, urine, and saliva to measure, screen, and monitor patient vital signs, oral, dental, cardiovascular, metabolic, and inflammatory diseases and conditions, mental health and social habits related to health, markers associated with oral, dental, cardiovascular, metabolic, and inflammatory diseases and conditions, in the nature of HbA1C blood panels, lipid blood panels, glucose blood panels, uric acid blood panels and inflammation blood panels, and oral fluid panels including in the nature of salivary markers for screening, assessment, and monitoring purposes | ACTIVE | — |
| 010 | medical apparatus for monitoring, screening, testing, measuring, and analyzing diagnostic biomarkers in patient blood, urine, and saliva and for use in measuring, screening and monitoring patient vital signs, oral and systemic health, and social habits related to health; Medical apparatus for monitoring diagnostic biomarkers in patient blood, urine, and saliva and for use in measuring, screening and monitoring patient vital signs, oral and systemic health, and social habits related to health, with integrated recorded software for monitoring oral and systemic health by analyzing biomarkers in patient blood, urine and saliva, sold as a unit; Medical devices for analyzing diagnostic biomarkers in patient blood, urine, and saliva and for use in measuring, screening and monitoring patient vital signs, oral, dental, cardiovascular, metabolic, and inflammatory diseases and conditions, mental health and social habits related to health, markers associated with oral, dental, cardiovascular, metabolic, and inflammatory diseases and conditions, blood panels in the nature of HbA1C blood panels, lipid blood panels, glucose blood panels, uric acid blood panels and inflammation blood panels, and oral fluid panels in the nature of salivary markers, with embedded software for monitoring oral and systemic health by analyzing diagnostic biomarkers in patient blood, urine and saliva, sold as a unit | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software for measuring, screening and monitoring patient vitals, various disease markers, social health markers, and oral and systemic health using blood, urinary and salivary analysis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 17, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 17, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 11, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 18, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 17, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 17, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 17, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 23, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 19, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 27, 2025 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Oct 27, 2025 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 10, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 10, 2025 | NWAP | NEW APPLICATION ENTERED | — |